But the fact remains they have not explained the reason for the increased enrollment requirement (there has been no recent review board meeting that could have precipitated this).
And they no longer seem to be saying that enrollment in all three trials will be done 1h10, and they no longer are saying they have cash through NDA filing.
Market Data 
Markets 
AI
